(Q58333416)

English

IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

scientific article published in September 2017

In more languages

Statements

scholarly article

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients (English)

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

corrigendum / erratum

Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.

0 references

Robert C. Stein

object named as

Rob C Stein

2

0 references

Hironobu Sasano

6

object named as

Hironobu Sasano

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

object named as

Carlo Palmieri

1

0 references

Fouzia Guestini

object named as

Fouzia Guestini

7

0 references

object named as

Xinxue Liu

3

0 references

author name string

Emma Hudson

4

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Hanna Nicholas

5

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Chris Holcombe

8

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Sophie Barrett

9

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Laura Kenny

10

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Sadie Reed

11

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Adrian Lim

12

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Larry Hayward

13

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

Sacha Howell

14

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

R Charles Coombes

15

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

language of work or name

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

publication date

September 2017

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

full work available at URL

https://doi.org/10.1007/S10549-017-4328-Z

object has role

published version

copyright license

Creative Commons Attribution 4.0 International

0 references

http://eprints.whiterose.ac.uk/126505/

content deliverer

White Rose Research Online

object has role

published version

copyright license

Creative Commons Attribution 4.0 International

0 references

Breast Cancer Research and Treatment

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

165

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

343-353

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

2

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

copyright license

Creative Commons Attribution 4.0 International

13 June 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s10549-017-4328-z

0 references

History of aromatase: saga of an important biological mediator and therapeutic target

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Breast cancer: current and future endocrine therapies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Estrone sulfate: production rate and metabolism in man.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Identification of steroid sulfate transport processes in the human mammary gland

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Estrone sulfate and dehydroepiandrosterone sulfate: Transactivation of the estrogen and androgen receptor.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

ErbB receptor signaling and therapeutic resistance to aromatase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Enzymatic basis of typical X-linked ichthyosis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

The role of estrogen receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4328-Z

21 January 2018

Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543190

30 November 2018

Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543190

30 November 2018

Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of cyclin D1 MRNA levels with clinico-pathological parameters and clinical outcome in human breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical oncology: why biopsying metastatic breast cancer should be routine

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroid sulfation Current concepts

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of aromatase inhibitors and body mass index on steroid hormone levels in women with early and advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of Steroid Sulfatase Expression in Human Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/28612226

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10549-017-4328-Z

1 reference

https://link.springer.com/article/10.1007%2Fs10549-017-4328-z

7 November 2018

10.1007/S10549-017-4328-Z

0 references

0 references

Dimensions Publication ID

0 references

0 references

0 references

2-s2.0-85032226093

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58333416&oldid=1934920134"